首页> 外文期刊>Saudi Pharmaceutical Journal >Nanogels as potential nanomedicine carrier for treatment of cancer: A mini review of the state of the art
【24h】

Nanogels as potential nanomedicine carrier for treatment of cancer: A mini review of the state of the art

机译:纳米凝胶作为潜在的治疗癌症的纳米药物载体:对现有技术的简要回顾

获取原文
获取外文期刊封面目录资料

摘要

Nanogels are being explored as drug delivery agents for targeting cancer due to their easy tailoring properties and ability to efficiently encapsulate therapeutics of diverse nature through simple mechanisms. Nanogels are proficiently internalized by the target cells, avoid accumulating in nontarget tissues thereby lower the therapeutic dosage and minimize harmful side effects. However, there is an urgent need for relevant clinical data from nanogels so as to allow translation of the nanogel concept into a viable therapeutic application for the treatment of cancer. This review highlights some of the recent progress in nanogels as a carrier in the field of nanomedicine for the treatment of cancer. The present review critically analyzes the use of extracellular pH targeting for nanogels, siRNA delivery, PEGylated nanogels, multi-responsive nanogels and intracellular delivery of nanogels for improved therapy of cancer.
机译:纳米凝胶由于其易于定制的特性和通过简单机制有效封装各种性质的治疗剂的能力,正在被研究为靶向癌症的药物递送剂。纳米凝胶可被靶细胞充分内在化,避免在非靶组织中积聚,从而降低治疗剂量并使有害副作用最小化。然而,迫切需要来自纳米凝胶的相关临床数据,以允许将纳米凝胶概念转化为用于治疗癌症的可行的治疗应用。这篇综述着重介绍了纳米凝胶作为纳米药物在癌症治疗领域的载体的最新进展。本综述严格分析了针对纳米凝胶,siRNA输送,聚乙二醇化纳米凝胶,多响应纳米凝胶和纳米凝胶的细胞内输送的细胞外pH靶向技术,以改善癌症的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号